Health Economics and Policy

Business & Profession Business and Innovation

07/11/2022 | Sponsored by Teleon | 2 min read

Teleon Surgical’s CEO, Mark Lansu, talks about the company’s vision for achieving sustainability in eye care

Subspecialties Retina

07/05/2022 | Geoffrey Potjewyd | 2 min read

How have delays caused by COVID-19 for anti-VEGF treatment affected AMD patients disease progression?

Business & Profession Health Economics and Policy

06/30/2022 | Julien Buratto | 4 min read

How can cryptocurrency and blockchain ultimately help ophthalmologists – and patients?

Subspecialties Neuro-ophthalmology

06/28/2022 | Friedemann Paul | 7 min read

Friedemann Paul explains the importance of NMOSD awareness

Subspecialties Retina

06/27/2022 | Geoffrey Potjewyd | 3 min read

A brief journey through the latest retina research

Business & Profession Cornea / Ocular Surface

06/24/2022 | Rajesh Sinha, Partha Biswas, Arindam Dey, Prashant Sada | 14 min read

What can be done to stop the epidemic of evaporative dry eye in India?

Business & Profession Business and Innovation

06/23/2022 | Duncan Welling | 8 min read

How do we facilitate ophthalmic innovation when nobody knows who knows what?

Business & Profession Practice Management

06/20/2022 | Amir-Mobarez Parasta | 5 min read

Reusable instruments have long been the status-quo, but is it time for a change?

Subspecialties Cornea / Ocular Surface

06/17/2022 | Maria Chen, Haishan Jang | 5 min read

Could regenerative peptide therapy pave the way for new treatment methods for severe dry eye?

Business & Profession Professional Development

06/09/2022 | Daniel Laby | 11 min read

Daniel Laby on building a career in sports and performance vision